Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

11.1%

6 terminated/withdrawn out of 54 trials

Success Rate

86.7%

+0.2% vs industry average

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

15%

6 of 39 completed trials have results

Key Signals

2 recruiting6 with results

Enrollment Performance

Analytics

Phase 1

23(45.1%)

Phase 2

15(29.4%)

Phase 3

7(13.7%)

N/A

5(9.8%)

Phase 4

1(2.0%)

51Total

Phase 1(23)

Phase 2(15)

Phase 3(7)

N/A(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (54)

Showing 20 of 54 trials

NCT07433335Phase 1Recruiting

A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis

Role: collaborator

NCT05516316Phase 1Completed

Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults

Role: collaborator

NCT04387409Phase 3Completed

Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic

Role: collaborator

NCT06168799Phase 2Completed

Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery

Role: collaborator

NCT04971161Phase 2Completed

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)

Role: collaborator

NCT06677918Phase 1Completed

Clinical Trial Investigating the Effects of EP395 Following an Inhaled Endotoxin Challenge in Healthy Adults

Role: collaborator

NCT06489028Phase 3Active Not Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

Role: collaborator

NCT06211049Phase 3Completed

Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea

Role: collaborator

NCT06191042Phase 1Completed

A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

Role: collaborator

NCT05365672Phase 2Recruiting

Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

Role: collaborator

NCT05389319Phase 1Suspended

A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults

Role: collaborator

NCT01798498Not ApplicableCompleted

Study for the Evaluation of the Efficacy and Safety of the Dermal Filler Princess® VOLUME in Nasolabial Folds

Role: collaborator

NCT03400059Not ApplicableCompleted

Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine

Role: collaborator

NCT03532126Completed

A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

Role: collaborator

NCT01744418Not ApplicableCompleted

Evaluation of the Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With ESRD

Role: collaborator

NCT01872208Not ApplicableCompleted

Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With PAD

Role: collaborator

NCT04379271Phase 2Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)

Role: collaborator

NCT04429919Phase 2Completed

AP-325 in Subjects With Peripheral Post-surgical Neuropathic Pain

Role: collaborator

NCT04263649Completed

Prospective Observational Study of the Power PICC Family of Devices and Accessories

Role: collaborator

NCT04277598Phase 1Completed

A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

Role: collaborator